Our Blog

12 Oct

Mesoblast join with Tasly for China deal

By Finance News

12 Oct 2018 – Regenerative medicine comapny Mesoblast (ASX:MSB) today announced completion of the transaction with Tasly Pharmaceutical Group to establish a strategic partnership in China for Mesoblast’s product candidates for heart failure.


Source: Finance News Network

Share this post

Related Posts

19 Feb

Stronger-than-expected results boost markets: Aus shares close 0.6% higher

19 Feb 2018 - The market rose steadily throughout the day due to stronger-than-expected... read more

16 Oct

Metro Glass kicks off strategic review, drops expenditure

16 Oct 2017 - Leading glass provider, Metro Glass (ASX:MPP) has downgraded it capital... read more

30 Aug

Telstra tolls: Aus shares 0.05% lower at noon

30 Aug 2017 - Telstra tolls: Aus shares 0.05% lower at noon. Telstra (ASX:TLS)... read more

04 Sep

ClearVue Technologies (ASX:CPV) on future of insulated glass

04 Sep 2018 - ClearVue Technologies Limited (ASX:CPV) Executive Chairman, Victor Rosenberg talks 2018... read more

05 Mar

Magnis Resources signs deal with Siemans AG

05 Mar 2018 - Graphite producer Magnis Resources (ASX:MNS) has inked a deal with... read more

07 Jun

Propel Funeral Partners bids for Newhaven Funerals

07 Jun 2018 - Propel Funeral Partners (ASX:PFP) has executed a conditional sale agreement... read more

07 Dec

Synlait Milk’s $37m kitchen to double infant formula powder

07 Dec 2017 - Dairy processing company, Synlait Milk (ASX:SM1) can now double the... read more

09 Aug

Banks bounce: Aus shares close 0.38% higher

09 Aug 2017 - Banks bounce: Aus shares close 0.38% higher. Helloworld Travel Limited... read more

23 Feb

Auswide Bank (ASX:ABA) 1H18 Results

23 Feb 2018 - Auswide Bank Limited (ASX:ABA) CEO Martin Barrett provides an update... read more

25 Jan

Tech stocks drop: Aus shares to open lower

25 Jan 2018 - It was a mixed session on Wall Street, and Australia’s... read more